Liz Lightstone

Professor Liz Lightstone is a Professor of Renal Medicine at Imperial College London's Faculty of Medicine and an Honorary Consultant Physician at the Imperial College Healthcare NHS Trust. She holds leadership roles as Faculty of Medicine Consul (Clinical) and Deputy Campus Director for the Hammersmith White City Campus. Her research focuses on lupus nephritis, pregnancy outcomes in kidney disease patients, and health inequalities. She has pioneered pre-pregnancy counseling for women with kidney disease, guiding over 1,000 such pregnancies.

Prof. Lightstone earned a first-class medical degree from Cambridge and a primary medical degree from King's College London, followed by MRC-funded fellowships for her PhD in Immunology at UCL and postdoctoral work at the ICRF Tumour Immunology Unit. Her academic contributions include co-chairing global initiatives like the SONG-GD steering committee and the UKKRC Glomerulonephritis Clinical Study Group. She has authored international guidelines for lupus nephritis and pregnancy management, and advises bodies like NICE and Nature Reviews Nephrology.

Her recent work includes leading the MELODY study on immune responses to SARS-CoV-2 in kidney patients and co-chairing the Imperial College's pandemic treatment guidelines. She has pioneered vaccination strategies for immunocompromised populations and advocates for gender equity in academic nephrology. Prof. Lightstone is a Trustee of Kidney Research UK and actively contributes to policy through committees like the ISN Western Europe Regional Board.